Keros Therapeutics Inc. (KROS)
KROS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$11.23
-3.27% on the day
Market cap
$222.7M
Micro cap
Revenue · 2025
$243.9M
Prior year not contiguous
Net income · 2025
$87.0M
35.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | KROS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001664710 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DELAWARE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $243.9M |
| Net income | $87.0M |
| Operating income | $67.6M |
| Net margin | 35.7% |
| Operating margin | 27.7% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $287.4M |
| Total assets | $338.0M |
| P/E (computed) | 2.6× |
| P/S (computed) | 0.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-09-10 |
| Latest annual report | 10-K | 2026-03-04 |
| Latest quarterly / interim | 10-Q | 2026-08-03 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 532 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SLGL | Sol-Gel Technologies Ltd. | $68.30 | -5.66% | $223.6M |
| SIGA | SIGA Technologies Inc. | $3.08 | -2.53% | $221.3M |
| PYXS | Pyxis Oncology Inc. | $1.85 | -7.96% | $221.2M |
| LRMR | Larimar Therapeutics Inc. | $2.16 | -14.63% | $224.4M |
| NATR | Nature's Sunshine Products Inc. | $12.76 | +0.39% | $224.5M |
| ZNTL | Zentalis Pharmaceuticals Inc. | $2.40 | -4.76% | $227.2M |
| GLSI | Greenwich LifeSciences Inc. | $15.50 | -12.77% | $227.5M |
| MGNX | MacroGenics Inc. | $3.42 | -8.06% | $217.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier